LabCompass

Mohamed Elnaggar

Medicine · Purdue University West Lafayette

Established · publishing since 1994

Publications

34

Citations

561

Est. group size

~1

Recurring co-author estimate

Active years

33

Publishing since 1994

Research summary
AI-generated

Mohamed Elnaggar's publication record spans a wide range of clinical medicine topics, including cardiovascular interventions (atrial fibrillation, coronary artery disease, stents and balloons), hematology and oncology (leukemia, biomarkers, drug delivery for cancer treatment), and other clinical areas like diabetic neuropathy and dermatology. Much of the work consists of systematic reviews and meta-analyses that synthesize existing clinical trial evidence, alongside some laboratory-based studies on disease biomarkers and cytogenetics. This breadth suggests a generalist clinical research profile rather than a single specialized focus.

Cardiovascular disease interventions (atrial fibrillation, coronary artery disease)Meta-analysis and systematic review methodologyHematologic malignancies (leukemia) and biomarkersDrug delivery systems for cancer and dermatologic conditionsClinical oncology and immunotherapy

Publication output has been variable over the last decade, with no output before 2020, sporadic activity through 2021-2024, and a notable increase in 2025-2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.8/year recently
1718192020: 6 publications202021: 1 publication212022: 5 publications222023: 1 publication232024: 1 publication242025: 9 publications9252026: 3 publications26
Recent publications
Publishes in
  • BMC Cardiovascular Disorders×3
  • Cureus×3
  • CHEST Journal×2
  • Research Square×2
  • The Lancet×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile